PortfoliosLab logoPortfoliosLab logo
OLMA vs. APP
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

OLMA vs. APP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Olema Pharmaceuticals, Inc. (OLMA) and AppLovin Corporation (APP). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

OLMA vs. APP - Yearly Performance Comparison


2026 (YTD)20252024202320222021
OLMA
Olema Pharmaceuticals, Inc.
-40.36%328.82%-58.45%472.65%-73.82%-73.54%
APP
AppLovin Corporation
-40.93%108.08%712.62%278.44%-88.83%44.57%

Fundamentals

EPS

OLMA:

-$1.75

APP:

$9.78

Total Revenue (TTM)

OLMA:

$0.00

APP:

$5.48B

Gross Profit (TTM)

OLMA:

$0.00

APP:

$4.82B

EBITDA (TTM)

OLMA:

-$161.30M

APP:

$4.12B

Returns By Period

The year-to-date returns for both stocks are quite close, with OLMA having a -40.36% return and APP slightly lower at -40.93%.


OLMA

1D
11.10%
1M
-38.39%
YTD
-40.36%
6M
52.30%
1Y
296.54%
3Y*
62.57%
5Y*
-15.39%
10Y*

APP

1D
6.97%
1M
-8.46%
YTD
-40.93%
6M
-44.61%
1Y
50.21%
3Y*
193.45%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OLMA vs. APP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OLMA
OLMA Risk / Return Rank: 9393
Overall Rank
OLMA Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
OLMA Sortino Ratio Rank: 9797
Sortino Ratio Rank
OLMA Omega Ratio Rank: 9696
Omega Ratio Rank
OLMA Calmar Ratio Rank: 9191
Calmar Ratio Rank
OLMA Martin Ratio Rank: 9090
Martin Ratio Rank

APP
APP Risk / Return Rank: 6464
Overall Rank
APP Sharpe Ratio Rank: 6666
Sharpe Ratio Rank
APP Sortino Ratio Rank: 6464
Sortino Ratio Rank
APP Omega Ratio Rank: 6464
Omega Ratio Rank
APP Calmar Ratio Rank: 6363
Calmar Ratio Rank
APP Martin Ratio Rank: 6464
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OLMA vs. APP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and AppLovin Corporation (APP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OLMAAPPDifference

Sharpe ratio

Return per unit of total volatility

1.84

0.67

+1.17

Sortino ratio

Return per unit of downside risk

4.00

1.29

+2.71

Omega ratio

Gain probability vs. loss probability

1.53

1.17

+0.35

Calmar ratio

Return relative to maximum drawdown

4.20

0.92

+3.28

Martin ratio

Return relative to average drawdown

11.00

2.24

+8.76

OLMA vs. APP - Sharpe Ratio Comparison

The current OLMA Sharpe Ratio is 1.84, which is higher than the APP Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of OLMA and APP, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


OLMAAPPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.84

0.67

+1.17

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.14

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.19

0.57

-0.75

Correlation

The correlation between OLMA and APP is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

OLMA vs. APP - Dividend Comparison

Neither OLMA nor APP has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OLMA vs. APP - Drawdown Comparison

The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum APP drawdown of -91.90%. Use the drawdown chart below to compare losses from any high point for OLMA and APP.


Loading graphics...

Drawdown Indicators


OLMAAPPDifference

Max Drawdown

Largest peak-to-trough decline

-96.26%

-91.90%

-4.36%

Max Drawdown (1Y)

Largest decline over 1 year

-62.55%

-49.99%

-12.56%

Max Drawdown (5Y)

Largest decline over 5 years

-94.36%

Current Drawdown

Current decline from peak

-72.64%

-45.75%

-26.89%

Average Drawdown

Average peak-to-trough decline

-75.04%

-42.76%

-32.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

23.88%

20.59%

+3.29%

Volatility

OLMA vs. APP - Volatility Comparison

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 37.35% compared to AppLovin Corporation (APP) at 21.74%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than APP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


OLMAAPPDifference

Volatility (1M)

Calculated over the trailing 1-month period

37.35%

21.74%

+15.61%

Volatility (6M)

Calculated over the trailing 6-month period

106.07%

58.38%

+47.69%

Volatility (1Y)

Calculated over the trailing 1-year period

162.85%

75.93%

+86.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

108.49%

77.95%

+30.54%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

107.61%

77.95%

+29.66%

Financials

OLMA vs. APP - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and AppLovin Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
1.33B
(OLMA) Total Revenue
(APP) Total Revenue
Values in USD except per share items